44284 Federal Register / Vol. 62, No. 161 / Wednesday, August 20, 1997 / Notices

services. HCFA does not require

exclusive use of this form for Medicaid.

42 CFR 424.32 and 42 CFR 414.40 are

regulations underlying the use of the

form HCFA–1500 and the information

captured on the form HCFA–1500,

including the use of diagnostic and

procedural coding systems. HCFA

solicits comments on any and all

aspects of the HCFA–1500, and the use

of diagnostic and procedural coding

systems: HCFA currently uses the most

current version of the ICD–9–CM and

CPT/HCPCS; Frequency: On occasion;

Affected Public: Business or other for

profit, not for profit institutions, State,

local or tribal government; Number of

Respondents: 976,239; Total Annual

Responses: 644,802,413; Total Annual

Hours: 46,797,008.

To obtain copies of the supporting

statement and any related forms and

instructions for the proposed paperwork

collection referenced above, E-mail your

request, including your address and

phone number, to JRudolph@hcfa.gov,

or call the Reports Clearance Office on

(410) 786–1324.

Written comments and

recommendations for the proposed

information collection should be faxed

(202) 395–6974 or sent directly to the

OMB Desk Officer designated at the

following address, by 08/28/97: OMB

Human Resources and Housing Branch,

Attention: Allison Eydt, New Executive

Office Building, Room 10235,

Washington, D.C. 20503.

Dated: August 18, 1997.

John P. Burke III,

HCFA Reports Clearance Officer, Office of

Information Services, Information

Technology Investment Management Group,

Division of HCFA Enterprise Standards,

Health Care Financing Administration.

[FR Doc. 97–22255 Filed 8–19–97; 8:45 am]

BILLING CODE 4120–03–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Health Resources and Services

Administration

Advisory Council; Notice of Meeting

In accordance with section 10(a)(2) of

the Federal Advisory Committee Act

(Pub. L. 92–463), announcement is

made of the following National

Advisory body scheduled to meet

during the month of September, 1997.

Name: Advisory Commission on

Childhood Vaccines (ACCV).

Date and Time: September 10, 1997; 9:00

a.m.–5:00 p.m.

Place: Parklawn Building, Conference

Rooms D and E, 5600 Fishers Lane,

Rockville, Maryland 20857.

The meeting is open to the public.

The full Commission will meet on

Wednesday, September 10 from 9:00 a.m. to

5:00 p.m.

Agenda: Agenda items will include, but

not be limited to: a report from the ACCV

Subcommittee on Vaccine Safety, an update

on the passage of excise tax legislation within

P.L. 105–34 on H.R. 2014, an overview of the

adjudication process under the National

Vaccine Injury Compensation Program, and

routine Program reports.

Public comment will be permitted before

lunch and at the end of the Commission

meeting on September 10. Oral presentations

will be limited to 5 minutes per public

speaker. Persons interested in providing an

oral presentation should submit a written

request, along with a copy of their

presentation to: Ms. Melissa Palmer,

Principal Staff Liaison, Division of Vaccine

Injury Compensation, Bureau of Health

Professions, Health Resources and Services

Administration, Room 8A–35, 5600 Fishers

Lane, Rockville, MD 20857, Telephone (301)

443–6593. Requests should contain the name,

address, telephone number, and any business

or professional affiliation of the person

desiring to make an oral presentation. Groups

having similar interests are requested to

combine their comments and present them

through a single representative. The

allocation of time may be adjusted to

accommodate the level of expressed interest.

The Division of Vaccine Injury Compensation

Program will notify each presenter by mail or

telephone of their assigned presentation time.

Persons who do not file an advance request

for presentation, but desire to make an oral

statement, may sign-up in Conference Room

D and E on September 10. These persons will

be allocated time as time permits.

Anyone requiring information regarding

the Commission should contact Ms. Palmer,

Division of Vaccine Injury Compensation,

Bureau of Health Professions, Health

Resources and Services Administration,

Room 8A–35, 5600 Fishers Lane, Rockville,

MD 20857, Telephone (301) 443–6593.

Agenda Items are subject to change as

priorities dictate.

Dated: August 14, 1997.

Jane Harrison,

Acting Director, Division of Policy Review

and Coordination.

[FR Doc. 97–22026 Filed 8–19–97; 8:45 am]

BILLING CODE 4160–15–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Health Resources and Services

Administration

Notice of Filing of Annual Report of

Federal Advisory Committee

Notice is hereby given that pursuant

to section 13 of Public Law 92–463, the

Annual Report for the following Health

Resources and Services

Administration’s Federal Advisory

Committees have been filed with the

Library of Congress:

Health Professions and Nurse Education

Special Emphasis Panel

The FY 1996 Report does not

encompass all of the Title VII or any of

the Title VIII programs of the Public

Health Service Act. These programs will

be incorporated in the FY 1997 Report.

Copies are available to the public for

inspection at the Library of Congress

Newspaper and Current Periodical

Reading Room, Room 1026, Thomas

Jefferson Building, Second Street and

Independence Avenue, SE.,

Washington, D.C. Copies may be

obtained from: Ms. Sherry Whipple,

Program Analyst, Peer Review Branch,

Bureau of Health Professions, Room 8C–

23, Parklawn Building, 5600 Fishers

Lane, Rockville, Maryland 20857,

Telephone (301) 443–5926.

Dated: August 14, 1997.

Jane Harrison,

Advisory Committee Management Office,

HRSA.

[FR Doc. 97–22024 Filed 8–19–97; 8:45 am]

BILLING CODE 4160–15–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Health Resources and Services

Administration

National Advisory Council on Migrant

Health; Notice of Meeting

AGENCY: Health Resources and Services

Administration, HHS.

ACTION: Notice of meeting.

In accordance with section 10(a)(2) of

the Federal Advisory Committee Act

(Public Law 92–463), announcement is

made of the following National

Advisory body scheduled to meet

during the month of September 1997:

Name: National Advisory Council on

Migrant Health (NACMH).

Date and Time: Starts: Thursday,

September 11, 1997, at 9:00 am; Ends:

Saturday, September 13, 1997, at 5:00

pm.

Place: Radisson Hotel City Centre, 31

West Ohio Street, Indianapolis, IN, 317/

635–2000.

The meeting is open to the public.

Agenda: This will be a meeting of the

Council. The agenda includes an

overview of general Council business

activities and priorities. Topics of

discussion will include a report on the

Interstate Migrant Education meeting,

the 1997 NACMH Recommendations,

and strategic planning for the Council.

In addition, the Council will be holding

its annual Advocate and Farmworker

Public Hearings. The Advocate Hearing

is scheduled for Friday, September 12

from 4 to 6 p.m. in the Panorama
Federal Register / Vol. 62, No. 161 / Wednesday, August 20, 1997 / Notices 44285

Ballroom at the Radisson Hotel City

Centre. The Farmworker Hearing is

scheduled for Saturday, September 13

from 9 a.m. to 5 p.m. in the Carter

Chapel at Indiana Wesleyan University,

4201 S. Washington St., Marion, Indiana

46953.

The Council meeting is being held in

conjunction with the 1997 Midwest

Farmworker Stream Forum, September

11–14, 1997. The Stream Forum also

will take place at the Radisson Hotel

City Centre, Indianapolis, IN.

Anyone requiring information

regarding the subject Council should

contact Susan Hagler, Migrant Health

Program, staff support to the National

Advisory Council on Migrant Health,

Bureau of Primary Health Care, Health

Resources and Services Administration,

4350 East West Highway, Room 7–5A1,

Bethesda, Maryland 20814, Telephone

301/594–4302.

Agenda items are subject to change as

priorities indicate.

Dated: August 14, 1997.

Jane Harrison,

Acting Director, Division of Policy Review

and Coordination.

[FR Doc. 97–22027 Filed 8–19–97; 8:45 am]

BILLING CODE 4160–15–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

John E. Fogarty International Center

for Advanced Study in the Health

Sciences; Notice of Meeting of the

Fogarty International Center Advisory

Board

Pursuant to Pub. L. 92–463, as

amended, notice is hereby given of the

thirty-seventh meeting of the Fogarty

International Center (FIC) Advisory

Board, September 23, 1997, in the

Lawton Chiles International House

(Building 16) at the National Institutes

of Health. The Research Awards

Subcommittee will meet on September

22 in the FIC Conference Room,

Building 31, Room B2C07, from 1:00

p.m. to approximately 4:00 p.m., and

will be closed to the public.

The meeting of the Board will be open

to the public from 8:30 a.m. to

approximately 12:00 noon.

The agenda will include a report by

the Director, FIC; a report on the status

of the planning and implementation

process of the Government Performance

and Results Act at the NIH; a

presentation on the results of the

evaluation of the International

Cooperative Biodiversity Groups

Programs; a presentation on the Institute

of Medicine’s Board on International

Health Report ‘‘America’s Vital Interest

in Global Health;’’ and an update on FIC

long-range planning activities.

In accordance with the provisions of

sections 552b(c)(4) and 552(c)(6), Title

5, United States Code and section 10(d)

of Pub. L. 92–463, as amended, the

entire meeting of the Research Awards

Subcommittee on September 22 will be

closed to the public from 1:00 p.m. to

approximately 4:00 p.m., and the Board

meeting on September 23 will be closed

to the public from 1:00 p.m. to

adjournment for the review of

applications for awards under the

Senior International Fellowship

Program; and the Fogarty International

Research Collaboration Awards and

HIV, AIDS and Related Illnesses

Collaboration Awards.

Paula Cohen, Committee Management

Officer, Fogarty International Center,

National Institutes of Health, Building

31, Room B2C08, 31 CENTER DR MSC

2220, Bethesda, Maryland 20892–2220,

telephone: 301–496–1491, will provide

a summary of the meeting and a roster

of the committee members upon

request.

Irene Edwards, Executive Secretary,

Fogarty International Center Advisory

Board, Building 31, Room B2C08,

telephone: 301–496–1491, will provide

substantive program information.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should

contact Ms. Cohen at least 2 weeks in

advance of the meeting.

(Catalog of Federal Domestic Assistance

Program No. 93.989, Senior International

Fellowship Awards Program, and 93.934,

Fogarty International Research Collaboration

Award.)

Dated: August 12, 1997.

Laverne Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–22032 Filed 8–19–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of General Medical

Sciences; Notice of Closed Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the National Institute

of General Medical Sciences meeting:

Committee Name: Biomedical Research &

Research Training Committee (BRRT)

Subcommittees—A, B, and C.

Date: November 6–7, 1997.

Time: 08:30 a.m. until 5:00 p.m.

Place: Hyatt Regency Hotel, One Bethesda

Metro Center, Bethesda, MD 20814.

Contact Person: Carol Latker, Ph.D., Irene

Glowinski, Ph.D., Arthur Zachary, Ph.D.,

Office of Scientific Review, Scientific Review

Administrator, NIGMS, 45 Center Drive,

Room 1AS–19D, Bethesda, MD 20892–6200.

Telephone: 301–594–3663.

Purpose: To review pre and post doctoral

service applications.

This meeting will be closed in accordance

with the provisions set forth in secs.

552b(c)(4) and 552b(c)(6). Title 5 U.S.C. The

discussions of these applications could

reveal confidential trade secrets or

commercial property such as patentable

material and personal information

concerning individuals associated with the

applications, the disclosure of which would

constitute a clearly unwarranted invasion of

personal privacy.

(Catalog of Federal Domestic Assistance

Program Nos. 93.821, Biophysics and

Physiological Sciences; 93.859,

Pharmacological Sciences; 93.862, Genetics

Research; 93.863, Cellular and Molecular

Basis of Disease Research; 93.880, Minority

Access Research Careers [MARC]; and

93.375, Minority Biomedical Research

Support [MBRS].)

Dated: August 12, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–22031 Filed 8–19–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Prospective Grant of Exclusive

License: Biomedical Uses of

Topoisomerase I Inhibitors Including

Camptothecin and Derivatives for

Retroviral Applications Including

Human Immunodeficiency Virus (HIV)

AGENCY: National Institutes of Health,

Public Health Service, DHHS.

ACTION: Notice.

SUMMARY: This is notice in accordance

with 15 U.S.C. 209(c)(1) and 37 CFR

404.7(a)(1)(i) that the National Institutes

of Health (NIH), Department of Health

and Human Services, is contemplating

the grant of a domestic exclusive license

to practice the inventions embodied in

the patents and patent applications

referred to below to Virologix

Corporation of New York, New York.

The patent rights in these inventions

have been assigned to the government of

the United States of America. The

patents and patent applications to be

licensed are: